What is the recommended management of ongoing seizures (post‑anoxic status epilepticus) in a patient after cardiac arrest?

Management of Post-Arrest Continuous Seizures (Post-Anoxic Status Epilepticus)

Immediate Treatment Approach

Treat ongoing seizures after cardiac arrest with antiseizure medications, but do NOT use prophylactic anticonvulsants in patients without seizures. 1

The 2020 International Consensus guidelines explicitly recommend against seizure prophylaxis (weak recommendation, very low-certainty evidence) but suggest treatment when seizures are diagnosed 1. This distinction is critical: prophylaxis does not prevent seizures or improve outcomes, but active seizures have the potential to worsen brain injury and should be treated 1.

First-Line Treatment: Benzodiazepines + EEG Monitoring

• Administer IV lorazepam 4 mg at 2 mg/min as initial therapy for any clinical seizure activity 1
• Initiate continuous or intermittent EEG monitoring immediately to detect epileptic activity, as clinical manifestations may be masked by sedation or absent entirely 1
• Use intermittent EEG to detect epileptiform activity in patients with clinical seizure manifestations 1
• Consider continuous EEG to monitor patients with diagnosed status epilepticus and treatment effects 1

Post-anoxic status epilepticus occurs in 23-31% of comatose cardiac arrest patients using continuous EEG monitoring 1. Many patients have electrographic seizures without visible clinical signs, making EEG essential 1.

Second-Line Antiseizure Medications

If seizures persist after benzodiazepines, use valproate or levetiracetam as first-choice agents based on their superior safety profiles 1:

Preferred Agents:

• Valproate 20-30 mg/kg IV over 5-20 minutes (88% efficacy, 0% hypotension risk) 1
• Levetiracetam 30 mg/kg IV over 5 minutes (68-73% efficacy, minimal cardiovascular effects) 1

Alternative Agents:

• Fosphenytoin 20 mg PE/kg IV at ≤150 PE/min (84% efficacy but 12% hypotension risk requiring cardiac monitoring) 1
• Phenobarbital 20 mg/kg IV over 10 minutes (58.2% efficacy but higher respiratory depression risk) 1

Note: Phenytoin is often ineffective for post-anoxic myoclonus specifically 1, though fosphenytoin remains an option for other seizure types.

Refractory Status Epilepticus (Third-Line)

If seizures continue despite benzodiazepines and one second-line agent 1:

• Propofol is highly effective for suppressing post-anoxic seizures and myoclonus (2 mg/kg bolus, then 3-7 mg/kg/hour infusion; 73% efficacy, 42% hypotension risk) 1
• Midazolam infusion (0.15-0.20 mg/kg load, then 1 mg/kg/min continuous infusion titrated to max 5 mg/kg/min; 80% efficacy, 30% hypotension risk) 1
• Pentobarbital (13 mg/kg bolus, then 2-3 mg/kg/hour; 92% efficacy but 77% hypotension risk) 1

Propofol is particularly effective for post-anoxic myoclonus and is already commonly used for sedation in ventilated patients 1.

Special Considerations for Post-Anoxic Myoclonus

Myoclonus requires specific antimyoclonic agents 1:

• Propofol is the most effective agent for post-anoxic myoclonus 1
• Clonazepam, valproate, and levetiracetam are antimyoclonic drugs that may be effective 1
• Phenytoin is often ineffective for myoclonus 1

Critical distinction: Recognize that myoclonus can be epileptic or non-epileptic in origin 1. Most post-anoxic myoclonus is non-epileptic 1. Use EEG to differentiate 1.

Evidence from the TELSTAR Trial (2024)

The most recent high-quality evidence comes from the 2024 TELSTAR trial, which randomized 172 post-cardiac arrest patients to protocolized antiseizure treatment versus standard care 1:

• Overall, aggressive suppression of all EEG epileptiform patterns did NOT improve outcomes (90% poor outcome in intervention vs 92% in control, p=0.68) 1
• However, subgroup analysis suggested benefit in patients with:
  • Unequivocal electrographic seizures (frequencies ≥2.5 Hz or evolving patterns) 1
  • Non-generalized periodic discharges 1

This means: Treat definite seizures aggressively, but do not necessarily treat all rhythmic/periodic EEG patterns that fall on the "ictal-interictal continuum" 1.

Prognostic Considerations That Should Guide Treatment Intensity

Do NOT assume all post-anoxic status epilepticus means poor outcome 1, 2, 3, 4:

Favorable Prognostic Indicators (suggesting aggressive treatment is worthwhile):

• Continuous EEG background before seizure onset (vs suppressed/burst-suppression) 3, 4
• Preserved N20 peaks on somatosensory evoked potentials 4
• NSE <70 μg/L at 48-72 hours 4
• Absence of ≥2 poor outcome ERC/ESICM criteria 3
• Higher discharge frequency on EEG (≥3 Hz) 3
• Non-motor seizure semiology 3

In patients WITHOUT multiple poor prognostic markers, 25% achieve good neurological outcome (CPC 1-2) despite status epilepticus 3. Among those with definite SE and favorable features, good outcome occurred in 100% when SE was successfully terminated with guideline-recommended treatment 3.

Poor Prognostic Indicators (suggesting treatment may be futile):

• Discontinuous or suppressed EEG background before SE onset 4
• Absent N20 peaks bilaterally 4
• Very high NSE (>70 μg/L) 4
• ≥2 ERC/ESICM poor outcome criteria 3

All patients with discontinuous background before SE onset died without regaining consciousness in one cohort 4.

Critical Pitfalls to Avoid

• Do NOT use prophylactic anticonvulsants in post-arrest patients without seizures—no benefit and risk of adverse effects 1
• Do NOT assume myoclonus with epileptiform discharges always means poor outcome—this may represent Lance-Adams syndrome, which is compatible with good recovery 1
• Do NOT allow overly aggressive sedation to confound prognostication—high-dose antiepileptics and sedatives can delay awakening and lead to premature withdrawal of care 1
• Do NOT rely solely on clinical examination—up to 50% of post-arrest seizures are non-convulsive and only detectable by EEG 1
• Do NOT treat all rhythmic/periodic EEG patterns aggressively—the TELSTAR trial showed no overall benefit from suppressing patterns that don't meet strict seizure criteria 1

Practical Treatment Algorithm

1. Detect seizures: Use continuous or intermittent EEG in all comatose post-arrest patients 1
2. Treat clinical or electrographic seizures: Start with lorazepam, then valproate or levetiracetam 1
3. For myoclonus specifically: Use propofol, clonazepam, valproate, or levetiracetam (NOT phenytoin) 1
4. For refractory SE: Escalate to propofol or midazolam infusion with continuous EEG guidance 1
5. Assess prognosis: Check EEG background continuity, SSEPs, NSE, and ERC/ESICM criteria before deciding treatment intensity 3, 4
6. In patients with favorable prognostic features: Treat aggressively with higher doses of levetiracetam (up to 4,250 mg) and valproate (up to 4,800 mg) to achieve SE cessation 3
7. Prolong observation: Patients may require 3+ weeks of treatment before awakening; do not prognosticate prematurely 5, 2

The key principle: Treat diagnosed seizures, but individualize treatment intensity based on multimodal prognostic markers rather than the presence of seizures alone 3, 4.